With less than two weeks to go, iCubed is again ready to play host to a diverse group of speakers, sponsors and attendees descending on Providence for the institute’s annual Vaccine Renaissance Conference. Please join us for several days of interesting and intense discussions covering the science community’s efforts to combat the world’s diseases.

This year’s gathering is scheduled over the course of four days, the first three taking place inside the Hotel Providence. Monday, October 13 will be focus on JanusMatrix. Tuesday, October 14 and Wednesday, October 15 will consist of lectures from several different sessions including: One Health/Animal Vaccines, Emerging Infectious Diseases/Biodefense, Cancer Vaccines and Immunotherapy, and Human Microbiome Immunopathogenesis and Vaccines. The conference will conclude with iCubed’s informatics training on Thursday, October 16 on the Providence campus of the University of Rhode Island.

When: October 13-16, 2014

Where: Hotel Providence. 139 Mathewson Street, Providence, R.I. 02903


Schedule8th Annual Vaccine Renaissance Conference Schedule

Special Guests: 

  • Pietro Bertino, Ph.D., Assistant Researcher, John A. Burns School of Medicine, University of Hawaii
  • Vanni Bucci, Ph.D., University of Massachusetts Dartmouth
  • Paul Coussens, Ph.D., Molecular Biology, Molecular Virology, Michigan State University
  • Lesley Dupuy, Ph.D., Virology Division, USAMRIID
  • Antonio Garmendia, M.V., Ph.D., Department of Pathobiology and Veterinary Science, University of Connecticut
  • Stephen Gregory, Ph.D., Brown Alpert Medical School
  • Bruno Guy, Ph.D., Research Department, Sanofi Pasteur
  • Dan Hoft, M.D., Ph.D., Division of Immunobiology, Saint Louis University Health Sciences Center
  • Amanda Jamieson, Ph.D., Molecular Microbiology and Immunology, Brown University
  • John Julias, Ph.D., United States Department of Homeland Security
  • Steven Katz, M.D., M.D. FACS, Boston University School of Medicine and Roger Williams Medical Center
  • Kimberly A. Kraynyak, Ph.D., Inovio Pharmaceuticals
  • Jake Kurtis, M.D., Ph.D., Department of Pathology and Laboratory Medicine, Brown University Medical School
  • Crystal Loving, Ph.D., USDA-ARS-National Animal Disease Center
  • Lewis Markoff, M.D., United States Food and Drug Administration
  • Polly Matzinger, Ph.D., Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases
  • Peter B. McGarvey, Ph.D., Innovation Center for Biomedical Informatics, Georgetown University Medical Center
  • Steve Meshnick, M.D., Ph.D., Department of Epidemiology, UNC Gillings School of Global Public Health
  • Thomas Nutman, M.D., Laboratory of Parasitic Diseases, National Institutes of Health
  • Amy Rosenberg, M.D., Food and Drug Administration
  • Edward T. Ryan, M.D., FACP, FIDSA, FASTMH, Division of Infectious Diseases, Massachusetts General Hospital, Harvard School of Public Health
  • Jennifer Smith, Ph.D., M.P.H., Department of Epidemiology, University of North Carolina Gillings School of Global Public Health
  • Marcelo Sztein, M.D., Center for Vaccine Development, University of Maryland
  • Stephen J. Thomas, M.D., Walter Reed Army Institute of Research (WRAIR)
  • Paulo Verardi, Ph.D., Department of Pathobiology and Veterinary Science, University of Connecticut
  • Amy Vincent, Ph.D., USDA-ARS, National Animal Disease Center
  • Judd Walson, M.D., M.P.H., Departments of Global Health, Medicine (Infectious Disease), Pediatrics and Epidemiology, University of Washington